Leveraging tax rates, rather than credits or tariffs, is key to supporting U.S. biomedical innovation
Amid increasing concern about how new federal policies could undermine drug development, a new white paper from the USC Schaeffer Center for Health Policy & Economics examines how tax policies could support America’s leadership in … Read More »